Authors
Loading...
In Vitro evaluation shows improved bioavailability and promising cytotoxic profile for curcumin, indicating the system's potential in BCS class IV drug delivery.
Csendes et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: